Chapter 2 Summary and Highlights
- Market Outlook
- Market Insights
Chapter 3 Market and Technology Background
- Definitions
- Immune System and Vaccines
- Components of the Immune System
- Cells of the Immune System
- Immune Response
- Major Histocompatibility Complex (MHC)
- Immunization and Vaccines
- Disorders of the Immune System
- Impact of Lifestyle on the Immune System
- How Vaccines Work
- Principles of Immunization
- Types of Immunity
- Advantages of Vaccination
- History of Vaccines
- Vaccines and Immunization, Overview
- Types of Vaccines
- Attenuated (Live) Vaccines
- Inactivated (Killed) Vaccines
- Toxoid Vaccines
- Subunit Vaccines
- Conjugate Vaccines
- Recombinant Vector Vaccines
- DNA Vaccines
- RNA Vaccines
- Immunization
- Advantages of Immunization
- Adjuvants and Excipients
- Pathogen Components
- Particulate Adjuvants
- Infectious Diseases Preventable by Vaccine
- Human Diseases
- Viral Diseases
- Bacterial Diseases
- Regulatory Aspects
- World Health Organization (WHO) Prequalified Vaccines
- New Product Approvals
- Recalls
- Significant Regulatory Developments in Vaccines
Chapter 4 Market Dynamics
- Overview
- Market Drivers
- Growing Awareness of Immunization
- Growing Investments and R&D
- New Vaccines
- Prevalence of Infectious Diseases
- Market Restraints
- Vaccine Development and Pricing
- Market Opportunities
- Increased Demand from Emerging Markets
- Therapeutic Vaccines
Chapter 5 Global Market for COVID-19 Vaccines
- Overview
- COVID-19 Vaccine Technologies
- Advent of mRNA Technology
- Impact of COVID-19 on Routine Infant Vaccination
- COVID-19 Disruptions
- Stagnating Global Coverage Rate
- Progress and Challenges by Country and Region
Chapter 6 Market Breakdown by Technology
- Global Market for Vaccine Technologies by Technology
- Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines
- Live-Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Other/Combination Vaccines
Chapter 7 Market Breakdown by Disease
- Global Market for Vaccine Technologies by Disease
- Pneumococcal
- Diphtheria and Tetanus
- HPV
- MMR
- Others
Chapter 8 Market Breakdown by Age Group
- Global Market for Vaccine Technologies by Age Group Treated
- Pediatrics
- Adolescents and Adults
Chapter 9 Market Breakdown by Region
- Global Market for Vaccine Technologies by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 10 Emerging Technologies and Developments
- Developments
- mRNA Vaccines
- Viral Vector Vaccines
- Nanoparticle Vaccines
- DNA Vaccines
- Virus-Like Particle (VLP) Vaccines
- Self-Amplifying RNA Vaccines
- Innovative Adjuvants
- AI and Computational Biology
- Personalized Vaccines
- Plant-Based Vaccines
Chapter 11 Competitive Landscape
- Competitive Landscape
- Company Share Analysis
Chapter 12 Company Profiles
- ABBOTT
- ASTRAZENECA
- BAVARIAN NORDIC
- BHARAT BIOTECH INTERNATIONAL LTD.
- EMERGENT BIOSOLUTIONS INC.
- GSK PLC.
- JOHNSON & JOHNSON SERVICES INC.
- MERCK & CO. INC.
- MITSUBISHI TANABE PHARMA CORP.
- PANACEA BIOTEC LTD.
- PFIZER INC.
- SANOFI
Chapter 13 Appendix: List of Acronyms
List of Tables
Summary Table A: Global Market for Vaccine Technologies, by Vaccine Type, Through 2028
Summary Table B: Global Market for COVID-19 Vaccines, 2019-2028
Table 1: History of Vaccines
Table 2: Types of Attenuated (Live) Vaccines
Table 3: Pros and Cons of Attenuated (Live) Vaccines
Table 4: Types of Inactivated (Killed) Vaccines
Table 5: Pros and Cons of Inactivated (Killed) Vaccines
Table 6: Types of Toxoid Vaccines
Table 7: Pros and Cons of Toxoid Vaccines
Table 8: Types of Subunit Vaccines
Table 9: Pros and Cons of Subunit Vaccines
Table 10: Types of Conjugate Vaccines
Table 11: Pros and Cons of Conjugate Vaccines
Table 12: Types of Recombinant Vector Vaccines, by Segment
Table 13: Pros and Cons of Recombinant Vector Vaccines
Table 14: Types of DNA Vaccines, by Segment
Table 15: Pros and Cons of DNA Vaccines
Table 16: Pros and Cons of RNA Vaccines
Table 17: Vaccine Excipient and Media Summary, Excipients included in U.S. Vaccines
Table 18: Vaccine-Preventable Human Viral Diseases
Table 19: Vaccine-Preventable Human Bacterial Diseases
Table 20: WHO Prequalified Vaccines, Feb. 2018-April 2020
Table 21: Newly Approved Vaccines, Dec. 2018-April 2020
Table 22: Emerging Viral Infectious Diseases, 1900-2020
Table 23: Global Market for COVID-19 Vaccines, 2019-2028
Table 24: WHO-Approved COVID-19 Vaccines: Companies and Technology Adopted
Table 25: COVID-19 Vaccines in the Pipeline
Table 26: Global Market for Vaccine Technologies, by Vaccine Type , Through 2028
Table 27: Global Market for Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, by Region, Through 2028
Table 28: Global Market for Live-Attenuated Vaccines, by Region, Through 2028
Table 29: Global Market for Inactivated Vaccines, by Region, Through 2028
Table 30: Global Market for Toxoid Vaccines, by Region, Through 2028
Table 31: Global Market for Other/Combination Vaccines, by Region, Through 2028
Table 32: Vaccines, by Disease Type
Table 33: Global Market for Vaccine Technologies, by Disease Type, Through 2028
Table 34: Global Market for Vaccine Technologies for Pneumococcal Disease, by Region, Through 2028
Table 35: Global Market for Vaccine Technologies for Diphtheria and Tetanus, by Region, Through 2028
Table 36: Global Market for Vaccine Technologies for HPV, by Region, Through 2028
Table 37: Global Market for Vaccine Technologies for MMR, by Region, Through 2028
Table 38: Seasonal Influenza Vaccines
Table 39: Global Market for Vaccine Technologies for Other Disease Segments, by Region, Through 2028
Table 40: Global Market for Vaccine Technologies, by Age Group, Through 2028
Table 41: Pediatric Vaccine Doses
Table 42: Pediatric/VFC Vaccine Price List, 2019
Table 43: Influenza Vaccine Price List, 2020
Table 44: Global Market for Vaccine Technologies for Pediatrics, by Region, Through 2028
Table 45: Price List of Vaccines for Adolescents and Adults
Table 46: Global Market for Vaccines for Adolescents and Adults, by Region, Through 2028
Table 47: Global Market for Vaccine Technologies, by Region, Through 2028
Table 48: North American Market for Vaccine Technologies, by Vaccine Type, Through 2028
Table 49: North American Market for Vaccine Technologies, by Country, Through 2028
Table 50: Immunization Schedule, Canada, 2020
Table 51: European Market for Vaccine Technologies, by Vaccine Type, Through 2028
Table 52: European Market for Vaccine Technologies, by Country, Through 2028
Table 53: Immunization Schedule, Germany, 2020
Table 54: Immunization Schedule, France, 2020
Table 55: Vaccination and Immunization Schedule, U.K., 2020
Table 56: Immunization Schedule, Italy, 2020
Table 57: Asia-Pacific Market for Vaccine Technologies, by Vaccine Type, Through 2028
Table 58: Asia-Pacific Market for Vaccine Technologies, by Country, Through 2028
Table 59: Immunization Schedule, China, 2020
Table 60: Immunization Schedule, Japan, 2020
Table 61: Immunization Schedule, India, 2020
Table 62: GAVI Support to India, 2001-2021
Table 63: Vaccination Coverage Estimates, Middle East and North Africa, 2014-2020
Table 64: Vaccination Coverage, Latin America, and Caribbean, 2014-2020
Table 65: RoW Market for Vaccine Technologies, by Vaccine Type, Through 2028
Table 66: RoW Market for Vaccine Technologies, by Sub-Region, Through 2028
Table 67: Abbott: Company Snapshot
Table 68: Abbott Laboratories: Financial Performance, 2022
Table 69: Astrazeneca: Company Snapshot
Table 70: AstraZeneca: Vaccines
Table 71: AstraZeneca: Recent Developments, 2021
Table 72: Bavarian Nordic: Company Snapshot
Table 73: Bavarian Nordic: Recent Developments, 2021
Table 74: Bharat Biotech: Company Snapshot
Table 75: Bharat Biotech: Vaccines
Table 76: Bharat Biotech: Recent Developments, 2020 and 2021
Table 77: Emergent BioSolutions: Company Snapshot
Table 78: Emergent BioSolutions: Vaccines
Table 79: Emergent BioSolutions: Recent Developments, 2020 and 2021
Table 80: GSK Plc: Company Snapshot
Table 81: GSK Plc: Vaccines Offered
Table 82: GSK Plc.: Recent Developments, 2020 and 2021
Table 83: Johnson & Johnson: Company Snapshot
Table 84: Johnson & Johnson: Recent Developments, 2021
Table 85: Merck & Co. Inc.: Company Snapshot
Table 86: Merck & Co. Inc.: Vaccines
Table 87: Merck & Co. Inc.: Recent Developments, 2020 and 2021
Table 88: Mitsubishi Tanabe Pharma Corp.: Company Snapshot
Table 89: Panacea Biotec Ltd.: Company Snapshot
Table 90: Pfizer Inc.: Company Snapshot
Table 91: Pfizer Inc.: Recent Developments, 2020 and 2021
Table 92: Sanofi: Company Snapshot
Table 93: Sanofi: Vaccines
Table 94: Sanofi: Recent Developments, 2021
Table 95: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Vaccine Technologies, by Vaccine Type, 2022-2028
Summary Figure B: Global Market for COVID-19 Vaccines, 2019-2028
Figure 1: Global Markets for Vaccine Technologies Market Dynamics
Figure 2: Global Market Share of COVID-19 Vaccines, by Technology, 2022
Figure 3: Global Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 4: Global Market for Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, 2020-2028
Figure 5: Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, by Region, 2020-2028
Figure 6: Global Market for Live-Attenuated Vaccines, 2020-2028
Figure 7: Global Market for Live-Attenuated Vaccines, by Region, 2020-2028
Figure 8: Global Market for Inactivated Vaccines, 2020-2028
Figure 9: Global Market for Inactivated Vaccines, by Region, 2020-2028
Figure 10: Global Market for Toxoid Vaccines, 2020-2028
Figure 11: Global Market for Toxoid Vaccines, by Region, 2020-2028
Figure 12: Global Market for Other/Combination Vaccines, 2020-2028
Figure 13: Global Market for Other/Combination Vaccines, by Region, 2020-2028
Figure 14: Global Market Share of Vaccine Technologies, by Disease Type, 2022
Figure 15: Global Market for Vaccine Technologies for Pneumococcal Disease, 2020-2028
Figure 16: Global Market for Vaccine Technologies for Pneumococcal Disease, by Region, 2020-2028
Figure 17: Global Market for Vaccine Technologies for Diphtheria and Tetanus, 2020-2028
Figure 18: Global Market for Vaccine Technologies for Diphtheria and Tetanus, by Region, 2020-2028
Figure 19: Global Market for Vaccine Technologies for HPV, 2020-2028
Figure 20: Global Market for Vaccine Technologies for HPV, by Region, 2020-2028
Figure 21: Global Market for Vaccine Technologies for MMR, 2020-2028
Figure 22: Global Market for Vaccine Technologies for MMR, by Region, 2020-2028
Figure 23: Global Market for Vaccine Technologies for Other Disease Segments, 2020-2028
Figure 24: Global Market for Vaccine Technologies for Other Disease Segments, by Region, 2020-2028
Figure 25: Global Market Share of Vaccine Technologies, by Age Group, 2022
Figure 26: Global Market for Vaccine Technologies for Pediatrics, 2020-2028
Figure 27: Global Market for Vaccine Technologies for Pediatrics, by Region, 2020-2028
Figure 28: Global Market for Vaccines for Adolescents and Adults, 2020-2028
Figure 29: Global Market for Vaccines for Adolescents and Adults, by Region, 2020-2028
Figure 30: Global Market for Vaccine Technologies, by Region, 2020-2028
Figure 31: Global Market Share of Vaccine Technologies, by Region, 2022
Figure 32: North American Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 33: North American Market Share for Vaccine Technologies, by Country, 2022
Figure 34: U.S. Market for Vaccine Technologies, 2020-2028
Figure 35: Canadian Market for Vaccine Technologies, 2020-2028
Figure 36: European Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 37: European Market Share for Vaccine Technologies, by Country, 2022
Figure 38: German Market for Vaccine Technologies, 2020-2028
Figure 39: Russian Market for Vaccine Technologies, 2020-2028
Figure 40: French Market for Vaccine Technologies, 2020-2028
Figure 41: U.K. Market for Vaccine Technologies, 2020-2028
Figure 42: Italian Market for Vaccine Technologies, 2020-2028
Figure 43: Spanish Market for Vaccine Technologies, 2020-2028
Figure 44: Rest of the European Market for Vaccine Technologies, 2020-2028
Figure 45: Asia-Pacific Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 46: Asia-Pacific Market Share for Vaccine Technologies, by Country, 2022
Figure 47: Chinese Market for Vaccine Technologies, 2020-2028
Figure 48: RoW Market Share for Vaccine Technologies, by Vaccine Type, 2022
Figure 49: RoW Market Share for Vaccine Technologies, by Sub-Region, 2022
Figure 50: Global Market Share for Vaccine Technologies, by Company, 2022
Figure 51: Abbott Laboratories: Financial Performance, 2021 and 2022
Figure 52: Abbott Laboratories: Revenue Share, by Business Unit, 2022
Figure 53: Abbott Laboratories: Revenue Share, by County/Region, 2022
Figure 54: AstraZeneca: Net Revenue, 2016-2020
Figure 55: AstraZeneca: Revenue Share, by Business Segment, 2020
Figure 56: AstraZeneca: Revenue Share, by Region/Country, 2020
Figure 57: Bavarian Nordic: Net Revenue, 2016-2020
Figure 58: Bavarian Nordic: Revenue Share, by Country, 2020
Figure 59: Emergent BioSolutions: Net Revenue, 2016-2020
Figure 60: GSK Plc: Net Revenue, 2016-2020
Figure 61: GSK Plc: Revenue Share, by Business Segment, 2020
Figure 62: GSK Plc: Revenue Share, by Region, 2020
Figure 63: Johnson & Johnson: Net Revenue, 2016-2020
Figure 64: Johnson & Johnson: Revenue Share, by Business Segment, 2020
Figure 65: Johnson & Johnson: Revenue Share, by Country/Region, 2020
Figure 66: Merck & Co. Inc.: Net Revenue, 2016-2020
Figure 67: Merck & Co. Inc.: Revenue Share, by Business Segment, 2020
Figure 68: Merck & Co. Inc.: Revenue Share, by Region/Country, 2021
Figure 69: Panacea Biotec Ltd.: Net Revenue, 2018-2022
Figure 70: Panacea Biotec Ltd.: Revenue Share, by Business Segment, 2022
Figure 71: Panacea Biotec Ltd.: Revenue Share, by Country/Region, 2022
Figure 72: Pfizer Inc.: Net Revenue, 2020-2022
Figure 73: Pfizer Inc.: Revenue Share, by Region/Country, 2022
Figure 74: Sanofi: Net Revenue, 2017-2021
Figure 75: Sanofi: Revenue Share, by Business Segment, 2020
Figure 76: Sanofi: Revenue Share, by Region, 2021
